Be in the know. 20 key reads for Wednesday…

  1. Lilly submits authorization request to FDA for antibody-based COVID-19 therapy (MarketWatch)
  2. Boeing’s Aviation Outlook Is Surprisingly Rosy. What It Means for the Stock. (Barron’s)
  3. The Labor Department’s Latest Blow Against ESG Investing (Barron’s)
  4. Trump Pushes for $1,200 Checks, PPP, and Airline Aid After Ending Stimulus Talks (Barron’s)
  5. House Report Attacks Tech Giants as Monopolists That Stifle Competition (Barron’s)
  6. What Time Is the 2020 Vice Presidential Debate Tonight? Here When It Starts and What to Watch. (Barron’s)
  7. Donald Trump’s COVID-19 treatment is similar to the average American hospitalized with coronavirus. Only faster. (USA Today)
  8. ECB’s Lagarde Pledges No Premature Removal of Monetary Support (Bloomberg)
  9. Wells Fargo Eliminates More Than 700 Jobs in Commercial Banking (Bloomberg)
  10. The US economy can survive without new stimulus until after the election and avoid a double-dip recession, Morgan Stanley’s investment chief says (Business Insider)
  11. Molson Coors (TAP) PT Raised to $62 at Guggenheim, Named ‘Best Idea’ (Street Insider)
  12. Trump says he’d approve 2nd round of stimulus checks after halting relief talks (Fox Business)
  13. SEE IT: Bill Murray joins FBN’s ‘The Claman Countdown’ (Fox Business)
  14. How podcasting became a new front in the streaming wars (Financial Times)
  15. Bill Gates Says Regulatory Approval For Antibody Drugs Could Sharply Reduce COVID-19 Mortality (Benzinga)
  16. Real-World Evidence: The Case of Peru (TrialSiteNews)
  17. Chevron vs. Exxon: Which Is a Better Buy? (U.S. News)
  18. Global Outlook Brightens as U.S. Consumer Imports Reach Pre-Pandemic Levels (Wall Street Journal)
  19. Covid-19 Antibody Drug From Glaxo, Vir Enters Final-Stage Testing (Wall Street Journal)
  20. Hedge funds make pandemic bet on insurance (Reuters)

Be in the know. 12 key reads for Tuesday…

  1. A Prescription for What Ails CVS, Walgreens (Wall Street Journal)
  2. U.S. Boosts Crude Sales to China, Forcing Saudis to Find Other Markets (Wall Street Journal)
  3. Prospects for New Round of Stimulus and an Economic Rebound Are Boosting Stocks (Barron’s)
  4. The Big Banks’ Earnings Are Coming. Here’s What to Expect. (Barron’s)
  5. China’s Economy Is on the Mend. Here’s Where the Rebound Is Still Uneven. (Barron’s)
  6. Trump’s Use of Regeneron Antibodies Will Help It Become a Big Seller, Say Analysts (Barron’s)
  7. Mark Cuban on the ‘best investment’ he ever made: ‘Most people don’t put in the time’ to do it (CNBC)
  8. Energy companies brace for Hurricane Delta impact, begin rig evacuations (Fox Business)
  9. ‘The Price Is Right’ returns to production with redesigned set, no audience (Fox Business)
  10. Peltz, Ackman, Icahn: How Their ‘Hostile’ Reputations Really Work (Institutional Investor)
  11. Hedge funds seek out emerging markets as Covid-19 continues to wreak havoc (Financial Times)
  12. U.S. Steps Up Efforts to Counter China’s Dominance of Minerals Key to Electric Cars, Phones (Wall Street Journal)

Be in the know. 14 key reads for Monday…

  1. Regeneron and Gilead Stock Jump as President Trump’s Health Remains in Focus (Barron’s)
  2. The Dirty Secrets Of ‘Clean’ Electric Vehicles (Forbes)
  3. Investors Pile Into U.K. Rental Homes as Covid Hits Young Buyers (Bloomberg)
  4. 9 Dividend Stocks That Can Help Anyone Looking for Income (Barron’s)
  5. Icahn, ex-protege fuel trucking-merge drama (New York Post)
  6. Growth stocks enjoying best year-to-date outperformance since 1979 – but value can soon bounce back, Bank of America says (Business Insider)
  7. Restaurants Prolong Outdoor Dining With Igloos, Heaters (Wall Street Journal)
  8. 3 win Nobel medicine award for hepatitis C virus discovery (MarketWatch)
  9. Abbott exec: Why better COVID-19 tests may help the U.S. get back to normal (MarketWatch)
  10. Charles Schwab Is Quietly One of the Biggest Banks in America. That’s a Problem. (Institutional Investor)
  11. Papa’s Got a Brand New Bag — how James Brown invented funk (Financial Times)
  12. Covid-19 Vaccine Deployment Would Give Global Economy a Lift Next Year (Wall Street Journal)
  13. The Stock Market’s Leaders Appear Most Vulnerable to Biden’s Tax Plan (Wall Street Journal)
  14. Regeneron co-founder on the antibody cocktail Trump is taking to fight coronavirus (FoxNews)

Be in the know. 10 key reads for Sunday…

  1. 8 Best Buffett Stocks to Buy for Dividends (US News)
  2. The Economic Legacy Of Shinzo Abe (NPR Planet Money)
  3. FAANGs Risk Ending Up Like the Nifty Fifty, Cooperman Worries (CIO)
  4. ‘Cobra Kai’ Never Dies With Teaser Video Announcing Season 3 Netflix Premiere Date (Maxim)
  5. Buy Terex Stock. Here’s Why It’s Barron’s Stock Pick This Week. (Barron’s)
  6. Watch Official Trailer for ‘Borat’ Sequel (Maxim)
  7. 2020 Chevrolet Corvette Daily-Driven Review: An Exotic You Can Race Comfortably to Costco (thedrive)
  8. Trump’s illness sparks new urgency for COVID-19 deal (The Hill)
  9. Ivermectin Could Turn COVID-19 Around. We Need To Find Out If It Works. (TrialSiteNews)
  10. Investors expect banks to kick off better Q3 earnings, but fear stimulus bridge for U.S. economy is crumbling (MarketWatch)

Be in the know. 20 key reads for Saturday…

  1. 7 reasons why investors should favour value stocks over growth, according to BofA (Business Insider)
  2. Wall Street claims the ‘Nasdaq Whale’ is back to pushing up tech stocks (New York Post)
  3. Being Smart is Not Enough (Farnam Street)
  4. Physicians Decided to Start Remdesivir Therapy for Trump (Bloomberg)
  5. JPMorgan’s quant guru details 2 ways Trump’s COVID-19 diagnosis can lift markets (Business Insider)
  6. The Nifty Fifty: Valuing Growth Stocks (Dividend Growth Investor)
  7. Elon Musk: Fusion Will Probably Be More Expensive Than Wind, Solar (Futurism)
  8. Dallas Fed’s Kaplan Lays Out Path for Additional Federal Reserve Aid, If Needed (Wall Street Journal)
  9. Will value survive its long winter? (Robeco)
  10. Warren Buffett’s charity dinner spurred the boss of an online-trading platform to embrace value investing (Business Insider)
  11. Think Like a Poker Player (Real Reutrns)
  12. Monopolies Are Distorting the Stock Market (Sparkline Capital)
  13. Warren Buffett was blasted as ‘washed up’ for not buying during the coronavirus crash. Berkshire Hathaway has announced $19 billion of investments this quarter (Business Insider)
  14. MiB: Dave Portnoy, founder of Barstool Sports (Bloomberg)
  15. What You Need To Know About Trump’s Experimental Coronavirus Antibody Treatment (Forbes)
  16. The Scientologist Billionaire Trying To Make A New Antibiotic (Forbes)
  17. The Richest Hedge Fund Managers On The 2020 Forbes 400 List (Forbes)
  18. Billionaire Backers: Explore The Big Money Behind Biden & Trump (Forbes)
  19. Letter from the Value Investing Mental Asylum or How I Embraced Stoics (Insider Monkey)
  20. ECRI Weekly Leading Index Update (Advisor Perspectives)